Pneumology - Original Articles
2 September 2025

Agreement between the one-minute sit-to-stand test and the six-minute walk test in assessing exercise capacity in patients with interstitial lung disease

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
0
Views
0
Downloads

Authors

The six-minute walk test (6-MWT) assesses functional exercise capacity in interstitial lung disease (ILD), providing key prognostic and functional insights. Logistical challenges, such as space and time limitations, limit its clinical use. The one-minute sit-to-stand test (1-MSTST) has emerged as a practical, space- and time-efficient alternative reflecting similar functional capacity. This study examined 1-MSTST and 6-MWT agreement in ILD patients and their correlations with pulmonary function tests and physiological responses. A prospective observational study was conducted on patients diagnosed with ILD at a tertiary care center. Patients underwent both 6-MWT and 1-MSTST at baseline, with follow-ups at 3 and 6 months. The agreement between these two tests was assessed using Lin’s concordance correlation coefficient (CCC). Secondary outcomes included correlations with pulmonary function parameters, such as forced vital capacity (FVC) and diffusion lung capacity for carbon monoxide, and physiological responses, including oxygen desaturation, heart rate variation, blood pressure variation, and perceived exertion measured by the Modified Borg Dyspnea Score. They were assessed using the Spearman correlation coefficient. A total of 59 patients completed the study. At baseline, a moderate agreement between 1-MSTST and 6-MWT was observed (CCC=0.37), which improved over time with CCC values of 0.49 at 3 months and 0.54 at 6 months, indicating increasing concordance. Both tests demonstrated similar oxygen desaturation responses and Borg score variations, highlighting their utility in detecting exercise-induced hypoxemia. While 6-MWT showed significant correlations with FVC (r=0.34, p=0.009) and peak expiratory flow rate (PEFR, r=0.39, p=0.002), 1-MSTST exhibited weaker associations with lung function parameters. The 1-MSTST is a feasible and practical alternative to the 6-MWT for assessing exercise capacity in ILD patients, particularly in resource-limited settings where space and time constraints hinder using the 6-MWT. Its ease of implementation and ability to detect exercise-induced desaturation make it a valuable tool for routine clinical assessment and follow-up of ILD patients.

Altmetrics

Downloads

Download data is not yet available.

Citations

Tremblay LabrecquePF, Dion G, Saey D. Functional clinical impairements and frailty in interstitial lung disease patients. ERJ Open Res 2022;8:00144-2022.
Shah Gupta R, Koteci A, Morgan A, et al. Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review. BMJ Open Respir Res 2023;10:e001291.
Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011;38:176-83.
Bae SS, Markovic D, Saygin D, et al. Associations between 6-minute walk distance and physiologic measures and clinical outcomes in myositis-associated interstitial lung disease. Rheumatology 2024;keae477.
Du Bois RM, Albera C, Bradford WZ, et al. 6-Minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur Respir J 2014;43:1421-9.
Bohannon RW, Crouch R. 1-Minute Sit-to-Stand Test: systematic review of procedures, performance, and clinimetric properties. J Cardiopulm Rehabil Prev 2019;39:2-8.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
Aguilaniu B, Roth H, Gonzalez-Bermejo J, et al. A simple semipaced 3-minute chair rise test for routine exercise tolerance testing in COPD. Int J Chron Obstruct Pulmon Dis 2014;9:1009-19.
Kaminsky DA, Whitman T, Callas PW. DLCO versus DLCO/VA as predictors of pulmonary gas exchange. Respir Med 2007;101:989-94.
Tsai MY, Huang KT, Hsu CY, et al. Reference values for the 1-minute sit-to-stand test to assess functional capacity and short-term mortality in people with idiopathic pulmonary fibrosis and fibrotic connective tissue related interstitial lung diseases: a prospective real-world cohort study. BMC Pulm Med 2025;25:61.
Crook S, Büsching G, Schultz K, et al. A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J 2017;49:1601871.
Vaidya T, Chambellan A, de Bisschop C. Sit-to-stand tests for COPD: a literature review. Respir Med 2017;128:70-7.
Briand J, Behal H, Chenivesse C, et al. The 1-minute sit-to-stand test to detect exercise-induced oxygen desaturation in patients with interstitial lung disease. Ther Adv Respir Dis 2018;12:1753466618793028.
Oishi K, Asami-Noyama M, Yamamoto T, et al. Detection of impaired gas exchange using the 1-minute sit-to-stand test in patients with interstitial lung disease. Respir Investig 2023;61:186-9.
Visser S, Lawler C, Fermoyle CC, et al. The 1-min sit-to-stand test as a screening tool to assess exercise-induced oxygen desaturation in normoxemic people with interstitial lung disease. Respir Med 2024;232:107748.
Araújo M, Neves I, Fernandes AL, et al. The 1-minute sit-to-stand test to evaluate fibrotic interstitial lung disease. Respir Med 2024;234:107833.
Chetta A, Aiello M, Foresi A, et al. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:170-5.
Hallstrand TS, Boitano LJ, Johnson WC, et al. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005;25:96-103.
Eaton T, Young P, Milne D, Wells AU. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:1150-7.
S S, Nagesh NJ, Suriyan S, Talatam RP. correlation of six minute walk test and lung function test variables (% fev1, % fvc, % dlco) in patients with connective tissue disorder – interstitial lung disease. JEMDS 2020;9:2690-4.
K SP, Gururaj P, R A, R R. Correlation of six minute walk test with spirometry indices in chronic obstructive pulmonary disease patients. JEMDS 2019;8:3749-53.
Reychler G, Boucard E, Peran L, et al. One minute sit-to-stand test is an alternative to 6MWT to measure functional exercise performance in COPD patients. Clin Respir J 2018;12:1247-56.
Gephine S, Bergeron S, Tremblay Labrecque PF, et al. cardiorespiratory response during the 1-min sit-to-stand test in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2020;52:1441-8.
Ozalevli S, Ozden A, Itil O, Akkoclu A. Comparison of the sit-to-stand test with 6 min walk test in patients with chronic obstructive pulmonary disease. Respir Med 2007;101:286-93.
Caminati A, Bianchi A, Cassandro R, et al. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009;103:117-23.
Tanriverdi A, Kahraman BO, Ozpelit E, Savci S. Test-retest reliability and validity of 1-minute sit-to-stand test in patients with chronic heart failure. Heart Lung Circ 2023;32:518-24.
Krauss E, Claas LH, Tello S, et al. European ILD registry algorithm for self-assessment in interstitial lung diseases. PLoS One 2025;20:e0316484.

Ethics approval

The study protocol was approved by the Ethics committee of the institution of All India Institute of Medical Sciences, Bhubaneswar with document number: (IEC/AIIMS BBSR/PG Thesis/2022-23/98), dated February 13, 2023.

How to Cite



“Agreement Between the One-Minute Sit-to-Stand Test and the Six-Minute Walk Test in Assessing Exercise Capacity in Patients With Interstitial Lung Disease”. 2025. Monaldi Archives for Chest Disease, September. https://doi.org/10.4081/monaldi.2025.3577.